Learn more

COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY-ACADEMIC COOP FOUND

Overview
  • Total Patents
    37
  • GoodIP Patent Rank
    42,470
  • Filing trend
    ⇩ 100.0%
About

COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY-ACADEMIC COOP FOUND has a total of 37 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INST OF BIOPHYSICS CHINESE ACAD OF SCIENCES, WUHAN KEQIAN BIOLOGICAL CO LTD and INST OF ANIMAL SCIENCE AND VETERINARY HUBEI ACAD OF AGRICULTURAL SCIENCES.

Patent filings in countries

World map showing COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY-ACADEMIC COOP FOUNDs patent filings in countries
# Country Total Patents
#1 Republic of Korea 28
#2 WIPO (World Intellectual Property Organization) 7
#3 China 1
#4 United States 1

Patent filings per year

Chart showing COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY-ACADEMIC COOP FOUNDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hwang Dong Youn 12
#2 Lee Kang In 11
#3 Kim Seong Jin 4
#4 Chung Ji Hyung 4
#5 Chung Ji-Hyung 3
#6 Lee Soo Hong 3
#7 Park Su Jin 2
#8 Kim Jin Su 2
#9 Kim Byoung Ju 2
#10 Naka Kazuhito 2

Latest patents

Publication Filing date Title
KR20170120085A Method for generating induced pluripotent stem cells from human-derived somatic cells using histone deacetylase inhibitor and bone morphogenetic protein pathway blocker
KR20170120084A Method for generating induced pluripotent stem cells from human-derived somatic cells using histone deacetylase inhibitor and bone morphogenetic protein pathway blocker
KR20170120077A Method for generating induced pluripotent stem cells using histone deacetylase inhibitor and bone morphogenetic protein pathway blocker
KR20170120080A Method for generating induced pluripotent stem cells from human-derived somatic cells
KR20170120083A Method for generating induced pluripotent stem cells from human-derived somatic cells using reprogramming-enhancing agents
KR20170120082A Method for generating induced pluripotent stem cells from human-derived somatic cells using reprogramming-enhancing agents
KR20170120076A Method for generating induced pluripotent stem cells
KR20170120086A Method for generating induced pluripotent stem cells using reprogramming-enhancing agents
KR20170120081A Method for generating induced pluripotent stem cells from human-derived somatic cells
KR20170120079A Method for generating induced pluripotent stem cells using histone deacetylase inhibitor and bone morphogenetic protein pathway blocker
KR20170120078A Method for generating induced pluripotent stem cells using histone deacetylase inhibitor and bone morphogenetic protein pathway blocker
KR20160128266A NOVEL mi-RNA hc-smR-S2-3 AND USE THEREOF
KR20170108325A Composition and method for differentiation adult stem cells into chondrocytes
KR20170096713A Stem cells for transplantation and pharmaceutical composition for inducing or facilitating angiogenesis comprising the same
KR20170087762A Method for preparing induced pluripotent stem cell using hydrogel
KR20170058509A Prophylactic or therapeutic kimchi for Helicobacter pylori-induced disease
KR20170048702A Novel peptides and cosmetic compositions for inhibiting skin aging or wrinkle formation comprising the same
KR20170040648A Pharmaceutical composition for preventing or treating diabetic foot ulcer
KR20170033559A Novel fusion peptides for gene delivery
KR20170025681A Pharmaceutical composition for preventing or treating degenerative arthritis